Compare Virgin Galactic Holdings, Inc. (SPCE) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Virgin Galactic Holdings, Inc. vs Zoetis Inc — how do they compare? Virgin Galactic Holdings, Inc. trades at $2.88 (market cap $498.02M), while Zoetis Inc trades at $73.7 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 62.5× Virgin Galactic Holdings, Inc.'s market cap, and Zoetis Inc pays a 2.81% dividend while Virgin Galactic Holdings, Inc. pays none. Which is the better fit depends on your goals.
| SPCE | ZTS | |
|---|---|---|
Market Cap | $498.02M | $31.14B |
Sector | Industrials | Health |
52-Week High | $7.52 | $156.76 |
52-Week Low | $2.17 | $71.91 |
Enterprise Value | $597.87M | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Virgin Galactic (SPCE) trades at $3.26, up 0.77% today, with technical indicators showing bullish momentum despite overbought RSI readings. The company continues to face significant fundamental challenges with negative profit margins (-19,781.3% net income margin) and declining revenue, though recent earnings have consistently beaten expectations. Cash flow remains negative but shows improvement trend from -$207M in 2022 to -$35M in 2025.
While technical momentum appears positive, SPCE's fundamental weakness and high cash burn present substantial risks. The stock offers speculative appeal for investors betting on space tourism commercialization, but requires careful risk management given persistent losses and competitive pressures in the emerging space sector.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
